Figure 7
Figure 7. Involvement of FPRs in the PMN-induced mobilization of inflammatory monocytes. (A) Extravasation of Gr1+ inflammatory monocytes in the air pouch of neutropenic mice (PMN depl) after stimulation with PAF combined with PMN secretion or individual granule proteins. ▨ indicate pretreatment with the FPR antagonist BOC-PLPLP. * indicates significant difference compared with respective treatment in the absence of the fpr antagonist. (B) Ca2+ mobilization in inflammatory monocytes in response to PMN secretion or individual granule proteins. Ca2+ mobilization was measured in the FACS in the presence or absence of the FPR antagonist BOC-PLPLP. * indicates significant difference compared with respective treatment in the absence of the fpr antagonist.

Involvement of FPRs in the PMN-induced mobilization of inflammatory monocytes. (A) Extravasation of Gr1+ inflammatory monocytes in the air pouch of neutropenic mice (PMN depl) after stimulation with PAF combined with PMN secretion or individual granule proteins. ▨ indicate pretreatment with the FPR antagonist BOC-PLPLP. * indicates significant difference compared with respective treatment in the absence of the fpr antagonist. (B) Ca2+ mobilization in inflammatory monocytes in response to PMN secretion or individual granule proteins. Ca2+ mobilization was measured in the FACS in the presence or absence of the FPR antagonist BOC-PLPLP. * indicates significant difference compared with respective treatment in the absence of the fpr antagonist.

Close Modal

or Create an Account

Close Modal
Close Modal